← All indications
Immunologic Deficiency Syndromes
Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
Subtype terms (8)
More specific conditions that are subtypes of Immunologic Deficiency Syndromes in the MeSH hierarchy.
- Agammaglobulinemia
29 drugs (27 approved, 2 experimental)
- Common Variable Immunodeficiency
33 drugs (26 approved, 7 experimental)
- Deltaretrovirus Infections
- Dysgammaglobulinemia
- HIV Infections
1095 drugs (462 approved, 633 experimental)
- Lymphopenia
11 drugs (8 approved, 3 experimental)
- Phagocyte Bactericidal Dysfunction
- Primary Immunodeficiency Diseases
83 drugs (45 approved, 38 experimental)
Drugs by status
Phase 3 trials (4)
Phase 2 trials (10)
Organizations
Organization Involved with Phase 4 Indications (82)
- CSL Behring
- Abbott
- Napo Pharmaceuticals
- Shire
- Bio Products Laboratory
- Bausch Health Companies
- Gilead Sciences
- ViiV Healthcare
- Merck
- Octapharma
- Grifols
- Baxalta
- GlaxoSmithKline
- Pronova BioPharma
- Boehringer Ingelheim
- St. Hope Foundation
- National Institutes of Health (NIH)
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institute on Drug Abuse (NIDA)
- Rodwick, Barry M., M.D.
- Chulalongkorn University
- Harvard University
- George Mason University
- University of Washington
- Howard University
- Instituto Mexicano del Seguro Social
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Instituto Nacional de Enfermedades Respiratorias
- Mater Misericordiae University Hospital
- +52 more
Organization Involved with Phase 3 Indications (87)
- PPD
- AbbVie
- Green Cross Corporation
- Bristol-Myers Squibb
- Schering-Plough
- CSL
- Merck Serono
- Pfizer
- Sanofi
- Sanofi-Aventis
- Tibotec
- Novartis
- Biocad
- FFF Enterprises
- INC Research
- Leadiant Biosciences, Inc.
- Parexel
- ProMetic Life Sciences
- Shaman Pharmaceuticals
- Sponsor GmbH
- Westat
- Omrix Biopharmaceuticals, Inc.
- ADMA Biologics, Inc.
- National Cancer Institute (NCI)
- National Eye Institute (NEI)
- National Heart, Lung, and Blood Institute (NHLBI)
- Willem Daniel Francois Venter
- University of Arizona
- Baylor University
- Case Western Reserve University
- +57 more
Organization Involved with Phase 2 Indications (54)
- Progenics
- ASIS Corporation
- Argos Therapeutics
- Atara Biotherapeutics
- Bellicum Pharmaceuticals
- Biocodex
- International Partnership for Microbicides, Inc.
- Neurotune AG
- Ortho Biotech, Inc.
- Tobira Therapeutics, Inc.
- The EMMES Corporation
- Fondazione Telethon
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- National Center for Complementary and Integrative Health (NCCIH)
- National Center for Research Resources (NCRR)
- National Institute of Dental and Craniofacial Research (NIDCR)
- National Marrow Donor Program
- University of Pennsylvania
- University of Pittsburgh
- AIDS Malignancy Consortium
- University of London
- Emory University
- Hoosier Cancer Research Network
- Institut National de la Santé Et de la Recherche Médicale, France
- Mahidol University
- McGill University
- Medical College of Wisconsin
- New York Medical College
- Ohio State University
- Sheffield Hallam University
- +24 more
Organization Involved with Phase 1 Indications (21)
- Amgen
- Chiron
- Sandoz
- Aldagen
- G D Searle
- Laboratorio Elea S.A.C.I.F. y A.
- Taiga Biotechnologies, Inc.
- Centers for Disease Control and Prevention, China
- National Human Genome Research Institute (NHGRI)
- United States Army
- Duke University
- Georgetown University
- Hospital Italiano de Buenos Aires
- Universidad Complutense de Madrid
- York University
- Capital Medical University
- University of Connecticut
- European Commission
- Ragon Institute of MGH, MIT and Harvard
- Chinese Academy of Medical Sciences
- Imperial College London
Organization Involved with Other Experimental Indications (30)
- Lederle
- Roche
- Astra
- Argus Pharmaceuticals
- Glaxo Wellcome
- Hoechst Marion Roussel
- Taiwan Liposome Company
- National Institute for Medical Research, Tanzania
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Rockefeller University
- Catholic University of Health and Allied Sciences
- China Academy of Chinese Medical Sciences
- Guangxi Medical University
- Guangzhou Medical University
- Hacettepe University
- Radboud University
- Shenzhen Geno-Immune Medical Institute
- University of Virginia
- Yonsei University
- Assiut University
- Columbia University
- University of California, Davis
- University of Cambridge
- Hebrew University
- Department of Veteran Affairs
- University of Western Ontario
- Warner Lambert
- The Fourth People’s Hospital of Nanning
- Jeffrey Modell Foundation
- Guilin Medical University